20% Returns in 1 Month: This Piramal Group Pharma Stock Reports 17% Revenue...

Piramal Pharma reported healthy Q1 FY27 growth across all three business segments, with strong EBITD...

Multibagger Pharma Company Expands into New Territory with Innovative Pedia...

The stock has delivered 85 per cent in 1 year and gave multibagger returns of 240 per cent in 2 year...

Breakout Stock with Stellar Q2 FY25 Results, Profit Surged by 350 Per cent;...